Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Betamethasone[1] Betamethasone (Betamethasone sodium phosphate)[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[9] 2, 28, 46, 56, 65, 83, 90, 96, 235 💬
2BETAMETHASONE ACIBUTATE[1] Betamethasone (Betamethasone sodium phosphate)[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
3Betamethasone mouthwash[1] Betamethasone (Betamethasone sodium phosphate)[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 56 💬
4Betamethasone Oral Solution Period 1 and Period 2[1] Betamethasone (Betamethasone sodium phosphate)[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
5Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days[2] Acetate,
Betamethasone (Betamethasone sodium phosphate)
[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 2 💬
6Betamethasone solution as intramuscular injection Period 1 and Period 2[1] Betamethasone (Betamethasone sodium phosphate)[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
7Intra-articular Compound Betamethasone[1] Betamethasone (Betamethasone sodium phosphate)[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
8Intraarticular betamethasone[1] Betamethasone (Betamethasone sodium phosphate)[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
9Phosphate and betamethasone acetate, 2 mL.[2] Acetate,
Betamethasone (Betamethasone sodium phosphate)
[6] Betamethasone (Betamethasone),
Betamethasone sodium phosphate (Betamethasone sodium phosphate),
Betamethasone valerate (Betamethasone valerate),
Betamethasone acetate (Betamethasone acetate),
Betamethasone dipropionate (Betamethasone dipropionate, BETAMETHASONE DIPROPIONATE USP, 0.05%),
Betamethasone benzoate (Betamethasone benzoate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 235 💬